This resource is an integral part of this Center grant. The resource has been existence for several years and has developed into a highly sought after, efficient, reliable resource to all investigators. The main role of the resource in the current project is to synthesize novel imaging proves which are not commercially available and to provide comprehensive in- house support and chemical/biochemical assistance to all projects. Specifically this includes: 1) synthesis of imaging drugs, reporter molecules and drug carriers which are not commercially available; 2) essential quality control and characterization of these compounds 3) peptide synthesis and development of synthetic strategies; 4) radiochemistry; 5) preparative isolation and chemical modification of biologically active molecules and; 6) providing expertise and training in various chemistry techniques. The existence of the chemistry resource has a number of benefits to each project, particularly where development and optimization of chemical techniques is not the primary research focus. As a whole the resource provides many functions that are equally important to each project (e.g. radioisotope handling) but an provide it much more efficiently and than each Project by itself. Centralization of personnel resources and supplies will therefore help to reduce the cost of the proposed research and result in a more efficient operation. Another important function of the core is to provide compounds, for research that have been 1) rigorously tested and conform the standards and synthesizes under identical, reproducible conditions, 2) are analyzed according to a standard protocol prior to use, and 3) synthesized in sufficient amounts so that they are available to all researchers. Finally, the core will also conduct its own research, as it has in the past, to further improve synthesis and design of chelates, reporters, fluorochromes and drug carriers. This is possible by the experienced fluorochromes and drug carriers. This is possible by the experienced staff members of this core and their expertise in different areas of chemistry including bioconjugation, chelate design, peptide synthesis, organic synthesis, protein chemistry and isolation, magnetic particle biosynthesis and analytical chemistry.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
3P50CA086355-02S1
Application #
6492313
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2001-08-07
Project End
2002-07-31
Budget Start
Budget End
Support Year
2
Fiscal Year
2001
Total Cost
$241,412
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Miller, Miles A; Askevold, Bjorn; Mikula, Hannes et al. (2017) Nano-palladium is a cellular catalyst for in vivo chemistry. Nat Commun 8:15906
Dubach, J Matthew; Kim, Eunha; Yang, Katherine et al. (2017) Quantitating drug-target engagement in single cells in vitro and in vivo. Nat Chem Biol 13:168-173
Vinegoni, Claudio; Fumene Feruglio, Paolo; Brand, Christian et al. (2017) Measurement of drug-target engagement in live cells by two-photon fluorescence anisotropy imaging. Nat Protoc 12:1472-1497
Iaconelli, Jonathan; Lalonde, Jasmin; Watmuff, Bradley et al. (2017) Lysine Deacetylation by HDAC6 Regulates the Kinase Activity of AKT in Human Neural Progenitor Cells. ACS Chem Biol 12:2139-2148
Arlauckas, Sean P; Garris, Christopher S; Kohler, Rainer H et al. (2017) In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy. Sci Transl Med 9:
Miller, Miles A; Weissleder, Ralph (2017) Imaging the pharmacology of nanomaterials by intravital microscopy: Toward understanding their biological behavior. Adv Drug Deliv Rev 113:61-86
Engblom, Camilla; Pfirschke, Christina; Zilionis, Rapolas et al. (2017) Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils. Science 358:
Pucci, Ferdinando; Garris, Christopher; Lai, Charles P et al. (2016) SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions. Science 352:242-6
Roy, Jeremy; Kim, Bongki; Hill, Eric et al. (2016) Tyrosine kinase-mediated axial motility of basal cells revealed by intravital imaging. Nat Commun 7:10666
Pfirschke, Christina; Engblom, Camilla; Rickelt, Steffen et al. (2016) Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy. Immunity 44:343-54

Showing the most recent 10 out of 316 publications